Applied Therapeutics Inc (NASDAQ:APLT)’s traded shares stood at 2.79 million during the latest session, with the company’s beta value hitting 1.73. At the last check today, the stock’s price was $1.27, to imply a decrease of -1.55% or -$0.02 in intraday trading. The APLT share’s 52-week high remains $10.62, putting it -736.22% down since that peak but still an impressive 5.51% since price per share fell to its 52-week low of $1.20. The company has a valuation of $147.77M, with an average of 14.46 million shares in intraday trading volume over the past 10 days and average of 4.81 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Applied Therapeutics Inc (APLT), translating to a mean rating of 1.83. Of 3 analyst(s) looking at the stock, 0 analyst(s) give APLT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.19.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Applied Therapeutics Inc (NASDAQ:APLT) trade information
After registering a -1.55% downside in the latest session, Applied Therapeutics Inc (APLT) has traded red over the past five days. The 5-day price performance for the stock is -37.44%, and -86.84% over 30 days. With these gigs, the year-to-date price performance is -62.09%. Short interest in Applied Therapeutics Inc (NASDAQ:APLT) saw shorts transact 13.56 million shares and set a 7.7 days time to cover.
The extremes give us $4 and $5 for target low and target high price respectively. As such, APLT has been trading -293.7% off suggested target high and -214.96% from its likely low.
Applied Therapeutics Inc (APLT) estimates and forecasts
Looking at statistics comparing Applied Therapeutics Inc share performance against respective industry, we note that the company has underperformed competitors. Applied Therapeutics Inc (APLT) shares are -72.81% down over the last 6 months, with its year-to-date growth rate lower than industry average at 11.27% against 17.50%. The rating firms project that company’s revenue will shrink -94.66% compared to the previous financial year.
Revenue forecast for the current quarter as set by 3 analysts is 100k. Meanwhile, for the current quarter, a total of 3 analyst(s) estimate revenue growth to 12.32M.Earnings reports from the last fiscal year show that sales brought in 9.99M and 190k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -99.00% before jumping 6,382.46% in the following quarter.
APLT Dividends
Applied Therapeutics Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
Applied Therapeutics Inc insiders hold 5.24% of total outstanding shares, with institutional holders owning 101.91% of the shares at 107.54% float percentage. In total, 101.91% institutions holds shares in the company, led by FRANKLIN RESOURCES INC. As of 2024-06-30, the company held over 10.21 million shares (or 8.1496% of shares), all amounting to roughly $47.69 million.
The next major institution holding the largest number of shares is VR ADVISER, LLC with 9.54 million shares, or about 7.6149% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $44.57 million.
We also have Franklin Strategic Series-Franklin Biotechnology Discove and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Applied Therapeutics Inc (APLT) shares. Going by data provided on Jul 31, 2024, Franklin Strategic Series-Franklin Biotechnology Discove holds roughly 3.45 shares. This is just over 2.97% of the total shares, with a market valuation of $4.43 million. Data from the same date shows that the other fund manager holds a little less at 3.15, or 2.71% of the shares, all valued at about 4.05 million.
